Treatment suitability, dosing, and results vary by patient
Last reviewed: May 14, 2026 Last updated: May 14, 2026 Written by: Jay Hastings, CEO of PlexusDx Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations
Science 296 , 24042407 (2002)
CD8 + cytotoxic T lymphocytes, reactive to TPO and Tg, promote glandular destruction, aided by increased ICAM-1 expression on follicular cells and elevated serum levels of VCAM-1 and TIMP-1
Patients with very low body fat may use a 5/16-inch needle
Recalls & Warnings April 04, 2012 Maker of Protein Drinks and Supplements Warned of Manufacturing Violations The FDA published a Warning Letter to Protica, Inc., a maker of protein drinks and supplements, regarding violations of manufacturing regulations discovered during inspection of its facility in Whitehall, PA